Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in

Bundamedik Tbk PT
IDX:BMHS

Watchlist Manager
Bundamedik Tbk PT Logo
Bundamedik Tbk PT
IDX:BMHS
Watchlist
Price: 199 IDR -1.49% Market Closed
Market Cap: Rp1.7T
Write Note Create Alert Ask AI

Wall St Price Targets

BMHS Price Targets Summary
Bundamedik Tbk PT

There are no price targets for BMHS.
BMHS Lowest Forecast
Wall Street Target
Not Available
BMHS Average Forecast
Wall Street Target
Not Available
BMHS Highest Forecast
Wall Street Target
Not Available
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Bundamedik Tbk PT Competitors:
Price Targets

Revenue
Forecast

9% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
9% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 6 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 2 years is 15%.

What are analyst estimates?

Gross Profit
Forecast

8% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss
8% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Over the last 6 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 1 year is 12%.

What are analyst estimates?

Operating Income
Forecast

-1% / Year
Past Growth
36% / Year
Estimated Growth
Estimates Accuracy
-21%
Average Miss
-1% / Year
Past Growth
36% / Year
Estimated Growth
Estimates Accuracy
-21%
Average Miss

Over the last 6 years, the compound annual growth rate for Operating Income has been -1%. The projected CAGR for the next 2 years is 36%.

What are analyst estimates?

Pre-Tax Income
Forecast

0% / Year
Past Growth
31% / Year
Estimated Growth
Estimates Accuracy
-24%
Average Miss
0% / Year
Past Growth
31% / Year
Estimated Growth
Estimates Accuracy
-24%
Average Miss

Over the last 6 years, the compound annual growth rate for Pre-Tax Income has been 0%. The projected CAGR for the next 1 year is 31%.

What are analyst estimates?

Net Income
Forecast

-8% / Year
Past Growth
271% / Year
Estimated Growth
Estimates Accuracy
-50%
Average Miss
-8% / Year
Past Growth
271% / Year
Estimated Growth
Estimates Accuracy
-50%
Average Miss

Over the last 6 years, the compound annual growth rate for Net Income has been -8%. The projected CAGR for the next 1 year is 271%.

What are analyst estimates?

Continue BMHS Research

Summary
BMHS intrinsic value, competitors valuation, and company profile.
DCF Valuation
BMHS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BMHS stock valuation using valuation multiples.
Wall St Estimates
BMHS price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BMHS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is BMHS's stock price target?
Not Available

BMHS does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Bundamedik Tbk PT?
Projected CAGR
15%

Over the last 6 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 2 years is 15%.

What is the Gross Profit forecast for Bundamedik Tbk PT?
Projected CAGR
12%

Over the last 6 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 1 year is 12%.

What is the Operating Income forecast for Bundamedik Tbk PT?
Projected CAGR
36%

Over the last 6 years, the compound annual growth rate for Operating Income has been -1%. The projected CAGR for the next 2 years is 36%.

What is the Pre-Tax Income forecast for Bundamedik Tbk PT?
Projected CAGR
31%

Over the last 6 years, the compound annual growth rate for Pre-Tax Income has been 0%. The projected CAGR for the next 1 year is 31%.

What is the Net Income forecast for Bundamedik Tbk PT?
Projected CAGR
271%

Over the last 6 years, the compound annual growth rate for Net Income has been -8%. The projected CAGR for the next 1 year is 271%.

Back to Top
ALPHA SPREAD
Follow us
Join 357,900+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.